In today's world, there is a growing need for new and innovative drugs, vaccines, biologicals, diagnostics and gene therapeutics, particularly now that people are getting older and more and more microorganisms are becoming resistant to drugs. JeanJacques Berthoud Pharmaceutical Company (Berthoud |Clompagnie Pharmaceutique or Berthoud for short) began operations in a small lab at McGill University in 1993, primarily focusing on meeting the chemical needs of local researchers. The company became known for its strong chemistry expertise and expanded both its operational lab footprint as well as its customer base. By 2010, Berthoud had outgrown its operational space and moved to its current 100,000 square foot facility in Montreal. The company provides drug discovery, development and manufacturing services to the pharmaceutical and biotechnology industries in Canada. The company is currently about to make an important strategic decision. It is becoming increasingly clear that in addition to surgery, chemotherapy, and radiation, cancer immunotherapy has grown into a new and very promising method of cancer treatment. Unlike other methods, immunotherapy focuses on using your body's own immune system to ght cancer. One factor is becoming more and more important over the last months. Recent statistics showed that the morbidity and mortality of COVEl 9 is higher in elderly and male patients. Specifically in cancer patients, those who are elderly andfor who have lung cancer, hematologic malignancy, advancedstage disease, active solid tumor, or a diagnosis of solid tumor in the past 5 years, or who had oncological surgery performed in the last 30 days, are at highest risk of an unfavorable outcome. However, statistical analysis also showed that namely in such cases immunotherapeutic drugs proved extremely efcient and can be literally lifesaving. There are challenges, however. First, most of the immunotherapeutic drugs are very new and their side effects are not yet properly studied. Secondly, these medications are usually very expensive and so far are mostly not covered by OHIP and similar insurance plans